Dextrose and Sodium Chloride (Baxter Healthcare Corporation)
Welcome to the PulseAid listing for the Dextrose and Sodium Chloride drug offered from Baxter Healthcare Corporation. This Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Baxter Healthcare Corporation |
| NON-PROPRIETARY NAME: | Dextrose and Sodium Chloride |
| SUBSTANCE NAME: | DEXTROSE MONOHYDRATE; SODIUM CHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1971-03-22 |
| END MARKETING DATE: | 0000-00-00 |
Dextrose and Sodium Chloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Dextrose and Sodium Chloride from Baxter Healthcare Corporation |
| LABELER NAME: | Baxter Healthcare Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.5; 450(g/100mL; mg/100mL) |
| START MARKETING DATE: | 1971-03-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0338-0073_c3344ea6-7a28-4c97-9759-04693648d712 |
| PRODUCT NDC: | 0338-0073 |
| APPLICATION NUMBER: | NDA016697 |
Other DEXTROSE MONOHYDRATE; SODIUM CHLORIDE Pharmaceutical Manufacturers / Labelers:
